Background: Spontaneous cervical artery dissection (sCAD) is a nonatherosclerotic vascular disease of unknown etiology. Mild elevation of total plasma homocysteine (tHcy) levels may be a risk factor for sCAD, but the precise mechanism remains unknown. On the other hand, mild hyperhomocysteinemia is also associated with ischemic stroke related to atherothrombotic or small artery disease. We undertook a case-control study to compare the prevalence of mild hyperhomocysteinemia and tHcy levels between patients with a first ischemic stroke due to sCAD and healthy volunteers, as well as patients with a first ischemic stroke due to atherothrombotic or small artery disease. Methods: Fasting tHcy levels were determined in 346 consecutive patients with a first ischemic stroke due to sCAD (n = 86) and atherothrombotic or small artery disease (n = 260) within 24 h after the onset of symptoms, and in 100 healthy volunteers. Results: Mild hyperhomocysteinemia was more prevalent in patients with sCAD causing ischemic stroke (n = 33, 38%) than in healthy volunteers (n = 23, 23%; p = 0.034), and less prevalent than in patients with ischemic stroke due to atherothrombotic or small artery disease (n = 149, 57%; p = 0.001). Mean fasting tHcy levels of patients with ischemic stroke caused by sCAD showed a trend to be higher (11.4 ± 3.8 μmol/l) than those of healthy volunteers (10.2 ± 3.0 μmol/l, p = 0.61), but were lower than those of patients with stroke due to atherothrombotic or small artery disease (13.6 ± 6.6 μmol/l, p = 0.002). Conclusion: Our results suggest that mild hyperhomocysteinemia may be a risk factor for sCAD causing ischemic stroke, but further studies are needed to identify a possible mechanism. This study confirms the association of hyperhomocysteinemia with ischemic stroke due to atherothrombotic or small artery disease.

Keywords:
Cerebrovascular disease, Stroke, Cervical artery dissection, Homocysteine
1.
Ducrocq X, Lacour JC, Debouverie M, Bracard S, Girard F, Weber M: Cerebral ischemic accidents in young subjects: a prospective study of 296 patients aged 16 to 45 years (in French). Rev Neurol (Paris) 1999;155:575–582.
2.
Nedeltchev K, der Maur TA, Georgiadis D, Arnold M, Caso V, Mattle HP, Schroth G, Remonda L, Sturzenegger M, Fischer U, Baumgartner RW: Ischaemic stroke in young adults: predictors of outcome and recurrence. J Neurol Neurosurg Psychiatry 2005;76:191–195.
3.
Gallai V, Caso V, Paciaroni M, Cardaioli G, Arning E, Bottiglieri T, Parnetti L: Mild hyperhomocyst(e)inemia: a possible risk factor for cervical artery dissection. Stroke 2001;32:714–718.
4.
Konrad C, Muller GA, Langer C, Kuhlenbaumer G, Berger K, Nabavi DG, Dziewas R, Stogbauer F, Ringelstein EB, Junker R: Plasma homocysteine, MTHFR C677T, CBS 844ins68bp, and MTHFD1 G1958A polymorphisms in spontaneous cervical artery dissections. J Neurol 2004;251:1242–1248.
5.
Pezzini A, Del Zotto E, Archetti S, Negrini R, Bani P, Albertini A, Grassi M, Assanelli D, Gasparotti R, Vignolo LA, Magoni M, Padovani A: Plasma homocysteine concentration, C677T MTHFR genotype, and 844ins68bp CBS genotype in young adults with spontaneous cervical artery dissection and atherothrombotic stroke. Stroke 2002;33:664–669.
6.
Kloss M, Wiest T, Hyrenbach S, Werner I, Arnold ML, Lichy C, Grond-Ginsbach C: MTHFR 677TT genotype increases the risk for cervical artery dissections. J Neurol Neurosurg Psychiatry 2006;77:951–952.
7.
Kelly PJ, Rosand J, Kistler JP, Shih VE, Silveira S, Plomaritoglou A, Furie KL: Homocysteine, MTHFR 677C→T polymorphism, and risk of ischemic stroke – Results of a meta-analysis. Neurology 2002;59:529–536.
8.
Hackam DG, Anand SS: Emerging risk factors for atherosclerotic vascular disease – a critical review of the evidence. JAMA 2003;290:932–940.
9.
Fassbender K, Mielke O, Bertsch T, Nafe B, Froschen S, Hennerici M: Homocysteine in cerebral macroangiography and microangiopathy. Lancet 1999;353:1586–1587.
10.
Hassan A, Hunt BJ, O’Sullivan M, Bell R, D’Souza R, Jeffery S, Bamford JM, Markus HS: Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction. Brain 2004;127:212–219.
11.
Gauthier G, Rohr J, Wildi E, Megret M: Spontaneous dissecting aneurysm of the internal carotid artery. General review of 205 published cases with 10 personal cases (in French). Schweiz Arch Neurol Psychiatr 1985;136:53–74.
12.
Benninger DH, Georgiadis D, Kremer C, Studer A, Nedeltchev K, Baumgartner RW: Mechanism of ischemic infarct in spontaneous carotid dissection. Stroke 2004;35:482–485.
13.
Baumgartner RW, Sidler C, Mosso M, Georgiadis D: Ischemic lacunar stroke in patients with and without potential mechanism other than small-artery disease. Stroke 2003;34:653–658.
14.
Adams HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE, Kase CS, Wolf PA, Babikian VL, Licatagehr EE, Allen N, Brass LM, Fayad PB, Pavalkis FJ, Weinberger JM, Tuhrim S, Rudolph SH, Horowitz DR, Bitton A, Mohr JP, Sacco RL, Clavijo M, Rosenbaum DM, Sparr SA, Katz P, Klonowski E, Culebras A, Carey G, Martir NI, Ficarra C, Hogan EL, Carter T, Gurecki P, Muntz BK, Ramirezlassepas M, Tulloch JW, Quinones MR, Mendez M, Zhang SM, Ala T, Johnston KC, Anderson DC, Tarrel RM, Nance MA, Budlie SR, Dierich M, Helgason CM, Hier DB, Shapiro RA, Brint S, Hoff J, Karanjia PN, Madden KP, Ruggles KH, Mickel SF, Gottschalk PG, Hansotia PI, Sorenson RW, Jacobson DM, Hiner BC, Mancl K, Gorelick PB, Riskin B, Mirza D, Kelly M, Bijari A, Kofman J, Dollear WC, Gomez CR, Malkoff MD, Riaz G, Schmidt JG, Malik MM, Banet G, Byer JA, Gamboa E, Stacy M, Bonnett A, Feldmann E, Wilterdink JL, Ricks L, Bruno A, Lakind E, Jeffrey DR, Mladinich EK, King M, Chapin JE, Carter S, Fisher M, Ameriso S, Macko RF, Martin A, Rothrock JF, Lyden PD, Brody ML, Kelly NM, Coull BM, Briley DP, Clark WM, Austin T, Degarmo PL, Adams HP, Dyken E, Yasar E, Bendixen B, Wojcieszek J, Kappelle J, Mitchell V, Frank J, Saver JL, Chadwick L, Mayman CI, Warach S, Tijerina ML, Miller A, Keilson M, Drexler E, Morgante L, Mandelbaum MA, Hassan R, Abbas DH, Olmstead CG, Sedlacek L, Gordon DL, Dendinger J, Love BB, Struck LK, Mueller C: Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35–41.
15.
Howard VJ, Sides EG, Newman GC, Cohen SN, Howard G, Malinow MR, Toole JF: Changes in plasma homocyst(e)ine in the acute phase after stroke. Stroke 2002;33:473–478.
16.
Arnold M, Kappeler L, Georgiadis D, Berthet K, Bousser MG, Baumgartner RW: Gender differences in spontaneous cervical artery dissection. Neurology 2006;67:1050–1052.
17.
Kawachi I, Colditz GA, Stampfer MJ, Willett WC, Manson JE, Rosner B, Speizer FE, Hennekens CH: Smoking cessation and time-course of decreased risk of coronary heart-disease in middle-aged women. Arch Intern Med 1994;138:169–175.
18.
Lindgren A, Brattstrom L, Norrving B, Hultberg B, Andersson A, Johansson BB: Plasma homocysteine in the Acute and convalescent phases after stroke. Stroke 1995;26:795–800.
19.
Brattstrom L, Wilcken DE: Homocysteine and cardiovascular disease: cause or effect? Am J Clin Nutr 2000;72:315–323.
20.
Christen WG, Ajani UA, Glynn RJ, Hennekens CH: Blood levels of homocysteine and increased risks of cardiovascular disease: causal or casual? Arch Intern Med 2000;160:422–434.
21.
Grau AJ, Brandt T, Forsting M, Winter R, Hacke W: Infection-associated cervical artery dissection: three cases. Stroke 1997;28:453–455.
22.
Guillon B, Levy C, Bousser MG: Internal carotid artery dissection: an update. J Neurol Sci 1998;153:146–158.
23.
Nurk E, Tell GS, Nygard O, Refsum H, Ueland PM, Vollset SE: Plasma total homocysteine is influenced by prandial status in humans. The Hordaland Homocysteine Study. J Nutr 2001;131:1214–1216.
24.
Ubbink JB, Vermaak WJ, Van der Merwe A, Becker PJ: The effect of blood sample aging and food consumption on plasma total homocysteine levels. Clin Chim Acta 1992;207:119–128.
25.
Nygard O, Vollset SE, Refsum H, Stensvold I, Tverdal A, Nordrehaug JE, Ueland M, Kvale G: Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA 1995;274:1526–1533.
26.
Must A, Jacques PF, Rogers G, Rosenberg IH, Selhub J: Serum total homocysteine concentrations in children and adolescents: results from the third National Health and Nutrition Examination Survey (NHANES III). J Nutr 2003;133:2643–2649.
27.
Jacques PF, Bostom AG, Wilson PW, Rich S, Rosenberg IH, Selhub J: Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort. Am J Clin Nutr 2001;73:613–621.
28.
Jacques PF, Rosenberg IH, Rogers G, Selhub J, Bowman BA, Gunter EW, Wright JD, Johnson CL: Serum total homocysteine concentrations in adolescent and adult Americans: results from the third National Health and Nutrition Examination Survey. Am J Clin Nutr 1999;69:482–489.
29.
Bushnell CD, Goldstein LB: Homocysteine testing in patients with acute ischemic stroke. Neurology 2002;59:1541–1546.
30.
Thom T, Haase N, Rosamond W, Howard VJ, Rumsfeld J, Manolio T, Zheng ZJ, Flegal K, Donnell C, Kittner S, Lloyd-Jones D, Goff DC Jr, Hong Y, Members of the Statistics Committee and Stroke Statistics Subcommittee, Adams R, Friday G, Furie K, Gorelick P, Kissela B, Marler J, Meigs J, Roger V, Sidney S, Sorlie P, Steinberger J, Wasserthiel-Smoller S, Wilson M, Wolf P: Heart Disease and Stroke Statistics – 2006 Update. A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006;113:e85–e151.
31.
Rubinstein SM, Peerdeman SM, van Tulder MW, Riphagen I, Haldeman S: A systematic review of the risk factors for cervical artery dissection. Stroke 2005;36:1575–1580.
32.
Baumgartner RW, Arnold M, Baumgartner I, Mosso M, Gonner F, Studer A, Schroth G, Schuknecht B, Sturzenegger M: Carotid dissection with and without ischemic events: local symptoms and cerebral artery findings. Neurology 2001;57:827–832.
33.
Soriente L, Coppola A, Madonna P, Cerbone AM, Di Minno G, Orefice G, D’Angelo A, Markus HS: Homozygous C677T mutation of the 5,10 methylenetetrahydrofolate reductase gene and hyperhomocysteinemia in Italian patients with a history of early-onset ischemic stroke. Stroke 1998;29:869–871.
© 2009 S. Karger AG, Basel
2009
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.